The emerging approach of this peptide represents a significant breakthrough in the care of the condition. Distinct from existing drugs, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide649610.thekatyblog.com/40133417/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment